Меню
Идёт набор NCT06729203

Effect of Ultrasound Cavitation on Insulin Resistance in Patients with Central Obesity in Female

Без фазы С лечением Central Obesity

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Ultrasound cavitation, Exercise.
Кому может быть актуально
Состояния в реестре: Central Obesity. Базовые параметры: 25 лет — 40 лет · Женщины.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Египет
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Обзор

The purpose of this study was to investigate the effect of ultrasound cavitation on insulin resistance, HbA1c and skin fold in patients with abdominal central obesity.

Подробное описание

Few researchers have detected the effects of ultrasonic cavitation on insulin resistance in subjects with central obesity. However, there were many conflicts and no clear evidence in the literature concerning the superiority of cavitation on body contour adjustment. Consequently, this study aimed to investigate the effects of ultrasound cavitation, aerobic exercise and a low-calorie dietary program on insulin resistance and total plasma HOMA ir and body contouring in female with abdominal obesity.

Вмешательства

  • Устройство Ultrasound cavitation
    Ultrasound Fat Cavitation (USFC) is the method in handling obesity, especially in destroying fat and shaping a particular part of the body. As one of the non-surgical correction methods, USFC is preferred at decreasing the risk of complications due to obesity.
  • Другое Exercise
    The female will stand on the cushioned tread and grasp by her both hands the two arms of the treadmill. Treadmill will adjust to apply moderate intensity training. It was used for 30 minutes divided into five-minutes warming up, twenty-minutes active exercise and five-minutes cooling down and it was used twice a week for twelve weeks.

Первичные конечные точки

  • HOMA ir [Срок оценки: "From enrollment to the end of treatment at 8 weeks"]
Вторичные конечные точки (2)
  • Skin fold by caliper [Срок оценки: "From enrollment to the end of treatment at 8 weeks"]
  • Waist circumference (WC) by tape measurement [Срок оценки: "From enrollment to the end of treatment at 8 weeks"]

Критерии участия

Критерии включения

  • Female subjects with central obesity.
  • Female participants aged between 25 to 40 years.
  • Body Mass Index (BMI) ranged from 30 to 35 kg/m2 as high BMI indicates more obesity and central obesity.
  • Waist circumference greater than 88 cm, indicative of abdominal obesity.
  • Diagnosed with insulin resistance (HOMA-IR > 2.9).
  • Sedentary lifestyle, defined as engaging in less than 150 minutes of moderate-intensity physical activity per week.
  • Willingness to provide informed consent and comply with study procedures.

Критерии исключения

  • • Subjects diagnosed with DM (HbA1c more than 6.5%).
  • History of metabolic disorders such as type 1 diabetes or thyroid disorders.
  • Subjects with BMI less than 30 kg/m2.
  • Subjects diagnosed with heart disease, liver as well as kidney diseases.
  • Subjects who take oral contraceptives.
  • Subjects with gestational Diabetes.
  • Pregnant or breastfeeding women were excluded from the study.
  • Use of weight-loss medications or supplements within the past six months.
  • Previous surgical procedures for weight loss or body contouring.
  • Contraindications to ultrasound therapy (e.g., metal implants in the abdomen, active skin infections).
  • Participation in another clinical trial within the last three months.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Простое слепое
Основная цель
Лечение

Центры проведения

Египет · 1 центр
  • Cairo University — Giza

Идентификаторы

NCT: NCT06729203 · 012/005421

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗